181 related articles for article (PubMed ID: 18400821)
1. Treatment of chronic hepatitis C in haemodialysis patients requires more ribavirin.
Slavenburg S; Drenth JP
Nephrol Dial Transplant; 2008 Jul; 23(7):2430; author reply 2430-1. PubMed ID: 18400821
[No Abstract] [Full Text] [Related]
2. [Treatment of infection due to hepatitis C virus in haemodialysis].
Hidalgo-Collazos P; Marín-Ventura L; Sánchez R; García-López L; Criado-Illana MT
Nefrologia; 2014; 34(1):132-3. PubMed ID: 24463875
[No Abstract] [Full Text] [Related]
3. Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantation.
Knapstein J; Galle PR; Zimmermann T
Dig Liver Dis; 2014 Jan; 46(1):88-9. PubMed ID: 24054768
[No Abstract] [Full Text] [Related]
4. Pegylated interferon for treatment in hemodialysis patients with chronic hepatitis C.
Koksal I
J Gastroenterol Hepatol; 2006 Mar; 21(3):491-4. PubMed ID: 16638088
[No Abstract] [Full Text] [Related]
5. Pegylated interferon alpha-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy.
Liu CH; Liang CC; Liu CJ; Tsai HB; Hung PH; Hsu SJ; Chen SI; Lin JW; Lai MY; Chen JH; Chen PJ; Chen DS; Kao JH
Gut; 2009 Feb; 58(2):314-6. PubMed ID: 19136527
[No Abstract] [Full Text] [Related]
6. Difficult management of triple therapy for chronic hepatitis C in a patient on haemodialysis.
Plana L; Peño L; Urquijo JJ; Diago M
Gastroenterol Hepatol; 2017 May; 40(5):356-358. PubMed ID: 27048917
[No Abstract] [Full Text] [Related]
7. Pushing the treatment envelope for chronic hepatitis C--is more necessarily better?
Lutchman G; Ghany M
Hepatology; 2005 Feb; 41(2):234-6. PubMed ID: 15657958
[No Abstract] [Full Text] [Related]
8. Peginterferon and ribavirin for hepatitis C.
Abramowicz M
N Engl J Med; 2007 Mar; 356(12):1270-1; author reply 1271. PubMed ID: 17378100
[No Abstract] [Full Text] [Related]
9. The treatment of viral hepatitis, present and future.
Rodés J
J Hepatobiliary Pancreat Surg; 2003; 10(2):163-7. PubMed ID: 14505150
[No Abstract] [Full Text] [Related]
10. Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients.
Zeuzem S
J Hepatol; 2008 Aug; 49(2):157-9. PubMed ID: 18554745
[No Abstract] [Full Text] [Related]
11. Comment on the PROVE1 and PROVE2 clinical trials: "I was taking a picture of Rapid Virological Response with telaprevir, but the background is unfocused!".
Baiocchi L; Lenci I; Carbone M; Angelico M
Hepatology; 2009 Nov; 50(5):1676-7. PubMed ID: 19876945
[No Abstract] [Full Text] [Related]
12. Long term suppressive therapy with pegylated interferon for chronic hepatitis C associated membranoproliferative glomerulonephritis.
Cua IH; Kwan V; Henriquez M; Kench J; George J
Gut; 2006 Oct; 55(10):1521-2. PubMed ID: 16966706
[No Abstract] [Full Text] [Related]
13. [Interferons alpha in the treatment of chronic HCV infections].
Halota W; Pawłowska M; Andrejczyn M
Przegl Epidemiol; 2004; 58(3):405-11. PubMed ID: 15730004
[TBL] [Abstract][Full Text] [Related]
14. Peginterferon and ribavirin for hepatitis C.
Duggan AE; Duggan JM
N Engl J Med; 2007 Mar; 356(12):1269; author reply 1271. PubMed ID: 17377169
[No Abstract] [Full Text] [Related]
15. Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C.
Annicchiarico BE; Siciliano M
Aliment Pharmacol Ther; 2004 Jul; 20(1):123-4; author reply 124. PubMed ID: 15225179
[No Abstract] [Full Text] [Related]
16. Ribavirin with interferon for hepatitis C in dialysis patients: efficacious and safe in the right patients in good hands.
Mutimer D
Gut; 2015 Feb; 64(2):190-1. PubMed ID: 24861270
[No Abstract] [Full Text] [Related]
17. Peginterferon and ribavirin for chronic hepatitis C.
Hoofnagle JH; Seeff LB
N Engl J Med; 2006 Dec; 355(23):2444-51. PubMed ID: 17151366
[No Abstract] [Full Text] [Related]
18. Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
Taylor LE; Rich JD; Tashima KT
N Engl J Med; 2004 Nov; 351(22):2340-2; author reply 2340-2. PubMed ID: 15564553
[No Abstract] [Full Text] [Related]
19. PEG-IFN, RBV dosing during chronic HCV re-treatment.
Highleyman L
IAPAC Mon; 2007 Feb; 13(2):55. PubMed ID: 17948601
[No Abstract] [Full Text] [Related]
20. A success story with chronic hepatitis C.
Weekley D; Yuen JC
J Ark Med Soc; 2005 Dec; 102(6):158-9. PubMed ID: 16381402
[No Abstract] [Full Text] [Related]
[Next] [New Search]
